Patent · US Active

Targeted mutant interferon-gamma and uses thereof

US11084859B2 · kind B2 · utility

4Cited by

5References

29Claims

0Family size

Assignees

Inventors

Nikolai KLEY · Waltham, US
Jan Tavernier · Balegem, BE
Frank Peelman · Gentbrugge, BE
Lennart ZABEAU · Evergem, BE

Key dates

Filing date	Oct 24, 2017
Grant date	Aug 10, 2021
Priority date	—
Expiry date	Oct 24, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates, in part, to chimeric proteins comprising mutant interferon-γ and their use as therapeutic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.